5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate Cancer

IMPORTANCE: 5α-reductase inhibitors (5ARIs) are widely used for benign prostatic hyperplasia despite controversy regarding potential risk of high-grade prostate cancer with use. Furthermore, the effect of 5ARIs on progression and prostate cancer death remains unclear. OBJECTIVE: To determine the ass...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Preston, Mark A., Wilson, Kathryn, Markt, Sarah C., Ge, Rongbin, Morash, Christopher, Stampfer, Meir J., Loda, Massimo F., Giovannucci, Edward, Mucci, Lorelei A., Olumi, Aria F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4122627/
https://ncbi.nlm.nih.gov/pubmed/24887392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2014.1600
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky